Showing results (51-60 of 157) with videos related to
Sort By:
Pageof 16
Cellular Immunology|August 1, 1991
The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individualsK C Stine, D S Tyler, S D Stanley, et al.Immunologic Research|May 8, 2001
HIV vaccine development at Duke University Medical CenterB F Haynes, H X Liao, H F Staats, et al.Physical Review Letters|August 7, 2019
Quantum Hypercube StatesL A Howard, T J Weinhold, F Shahandeh, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1987
Management of human immunodeficiency virus-associated thrombocytopenia with intravenous gamma globulinJ Kurtzberg, H S Friedman, T R Kinney, et al.AIDS Research and Human Retroviruses|August 1, 1988
Cellular immune response to viral peptides in patients exposed to HIVP M Ahearne, T J Matthews, H K Lyerly, et al.Cancer Research|January 1, 1996
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activationJ F Toso, C Oei, F Oshidari, et al.The Journal of Infectious Diseases|June 1, 1995
Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env geneM A Egan, W A Pavlat, J Tartaglia, et al.AIDS Research and Human Retroviruses|June 1, 1988
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoproteinM A Skinner, R Ting, A J Langlois, et al.Journal of Immunological Methods|April 15, 2014
Setting objective thresholds for rare event detection in flow cytometryAdam J Richards, Janet Staats, Jennifer Enzor, et al.The Journal of Experimental Medicine|August 1, 1988
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell linesS Chaffee, J M Leeds, T J Matthews, et al.Pageof 16